Patient Satisfaction and Quality of Life Impact - PecFent® (Qualipec)
National multicenter, prospective, observational study in cancer patients with chronic background pain and breakthrough pain to whom PecFent® has been prescribed under pragmatic condition by a specialist in the treatment of cancer pain conditions.
• Study objectives include assessment of early treatment satisfaction.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||A Spanish , Multicentre, Open-label, Observational Study to Assess Quality of Life and Satisfaction in Subjects Taking PecFent® for the Treatment of Breakthrough Cancer Pain (BTPc)|
- Satisfaction [ Time Frame: Satisfaction will be assessed approximately 1 hour after each breakthrough pain (BTPc) episode treated with PecFent® from completion of titration through Day 7 ] [ Designated as safety issue: No ]Satisfaction will be assessed using a 4-point Likert scale.
|Study Start Date:||September 2012|
|Estimated Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01698645
|Contact: Yolanda Riesgo, MD||+ 34 firstname.lastname@example.org|
|Hospital 12 de Octubre||Recruiting|
|Madrid, Spain, 28041|
|Contact: Hernan Cortes, MD + 34 913 908 349 email@example.com|
|Principal Investigator: Hernan Cortes, MD|